January 10, 2017 07:57 AM EST
Pharma

Fresh from grab­bing Shire’s mR­NA work, RaNA dis­clos­es a $51M raise

John Carroll

Editor & Founder

RaNA Ther­a­peu­tics is well along the way to fi­nanc­ing its next stage of de­vel­op­ment. A day af­ter the RNA spe­cial­ist took for­mal con­trol of Shire …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Safe­ty con­cerns and tri­al holds for pe­di­atric RSV vac­cines prompt cau­tion from FDA ad­comm

In­side Iso­mor­phic Labs: Demis Has­s­abis’ lab-free vi­sion for biotech’s AI fu­ture

Lon­za looks to de­part cap­sule and health in­gre­di­ents as it un­der­goes re­struc­ture

'Se­ri­ous liv­er in­jury' cas­es lead FDA to call for mon­i­tor­ing of Ocali­va pa­tients

Pfiz­er shares pos­i­tive Phase 3 re­sults in breast can­cer sub­set 

sponsored

The key to faster, more im­pact­ful re­search? Put pa­tients in the dri­ver’s seat

A service from the Financial Times